A clinical trial to test the effectiveness of a new, plant-based oral drug to treat type 2 diabetes has produced some ...

Quest Diagnostics DGX has achieved impressive growth over the past year, with its shares rising 38%. It has outperformed the industry’s 7.7% rise and the S&P 500 composite’s 17.1% gain. Presently ...